Cargando…
Primary TSC2(-/meth) Cells Induce Follicular Neogenesis in an Innovative TSC Mouse Model
Cutaneous lesions are one of the hallmarks of tuberous sclerosis complex (TSC), a genetic disease in which mTOR is hyperactivated due to the lack of hamartin or tuberin. To date, novel pharmacological treatments for TSC cutaneous lesions that are benign but still have an impact on a patient’s life a...
Autores principales: | Bernardelli, Clara, Chiaramonte, Eloisa, Ancona, Silvia, Sirchia, Silvia M., Cerri, Amilcare, Lesma, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456283/ https://www.ncbi.nlm.nih.gov/pubmed/36077111 http://dx.doi.org/10.3390/ijms23179713 |
Ejemplares similares
-
Differential Modulation of Matrix Metalloproteinases-2 and -7 in LAM/TSC Cells
por: Ancona, Silvia, et al.
Publicado: (2021) -
TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival
por: Lesma, Elena, et al.
Publicado: (2014) -
Anti-EGFR Antibody Efficiently and Specifically Inhibits Human TSC2(−)/(−) Smooth Muscle Cell Proliferation. Possible Treatment Options for TSC and LAM
por: Lesma, Elena, et al.
Publicado: (2008) -
The TSC1-TSC2 complex consists of multiple TSC1 and TSC2 subunits
por: Hoogeveen-Westerveld, Marianne, et al.
Publicado: (2012) -
Tumor Suppressors TSC1 and TSC2 Differentially Modulate Actin Cytoskeleton and Motility of Mouse Embryonic Fibroblasts
por: Goncharova, Elena A., et al.
Publicado: (2014)